Alberta Investment Management Corp (AIMCo)’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-19,335
Closed -$280K 1294
2022
Q2
$280K Buy
+19,335
New +$330K ﹤0.01% 1131

Other funds holding HCAT

Alberta Investment Management Corp (AIMCo)'s HCAT Position: Q3 2022 in Review

Alberta Investment Management Corp (AIMCo) sold out of Health Catalyst (HCAT) in Q3 2022, closing a stake of 19,335 shares — an estimated $280K sold.

Alberta Investment Management Corp (AIMCo) first reported a position in HCAT in Q2 2022 and held it in 1 quarter. The position peaked at $280K in Q2 2022. 171 funds tracked by Wall St. Rank hold HCAT as of Q3 2022.

  • Alberta Investment Management Corp (AIMCo) reported no remaining Health Catalyst position as of Q3 2022 after selling out during the quarter.
  • Alberta Investment Management Corp (AIMCo) sold 19,335 Health Catalyst shares in Q3 2022, an estimated $280K.
  • Alberta Investment Management Corp (AIMCo) first reported a position in Health Catalyst in Q2 2022 and held it in 1 quarter.
  • Alberta Investment Management Corp (AIMCo)'s Health Catalyst position peaked at $280K in Q2 2022.
  • 171 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2022.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q3 2022, filed 14 Nov 2022.